were treated with JA as described in 'Method' section. The GUS expression activities from control seedlings (transformed with no GUS), CaMV35S, EFCFS, EFCFS-HS-1, EFCFS-HS-2 and EFCFS-HS-3 promoter constructs were monitored at 0 and 48 h of posttreatment. The data were presented as mean of three-independent experiments for each construct. Statistical analysis showed a P value of \0.003, indicating highly significant. b Real-time PCR-based relative of GUS transcript accumulation (uidA-mRNA) in whole seedlings expressing CaMV35S, EFCFS, EFCFS-HS-1, EFCFS-HS-2 and EFCFS-HS-3 promoter constructs, 0 and 48 h post-treatment with JA. The data were presented as an average fold differences of GUS transcript of two-independent experiments. Each bar represents fold difference in transcript level of the GUS gene in transgenic plants in comparison to that obtained in transgenic plants expressing CaMV35S (taken as 1) promoter. c Electrophoresis of RT-dependent PCR amplifications of GUS transcripts from total RNA (DNaseI treated) obtained from transgenic plant expressing CaMV35S, EFCFS, EFCFS-HS-1, EFCFS-HS-2 and EFCFS-HS-3 constructs. d Electrophoresis of RT-dependent PCR amplifications of GAPDH transcripts from total RNA (DNaseI treated) from transgenic plant expressing CaMV35S, EFCFS, EFCFS-HS-1, EFCFS-HS-2 and EFCFS-HS-3 promoter constructs
